Sunita Tools Ltd (544001)
CyclicalScore breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹773.35 |
| Market Cap | ₹476.08 Cr |
| P/E Ratio | 119.4 |
| ROCE | 16.7% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -10.85% |
| Debt/Equity | — |
| Sales Growth | -0.46% |
| 52-Week Range | ₹553 — ₹1,123.85 |
| Sector | Industrial Manufacturing |
Strengths
- ROCE of 16.70% indicates decent capital efficiency
- Latest quarter shows ₹15 Cr sales and ₹3 Cr net profit, a 20% margin
- Small-cap industrial niche may offer specialization
- Stock is down about 31% from its 52-week high, reducing some froth
Concerns
- P/E of 119.4 is extremely rich against shrinking earnings
- Sales growth -0.46% and profit growth -10.85% show deteriorating fundamentals
- Piotroski F-Score of 3/9 signals poor financial health
- No dividend and missing book value/debt data leave balance-sheet risk unquantified
AI Analysis
Let me start with what I see. Sunita Tools Ltd trades at ₹773.35, a market cap of ₹476 Cr, and a P/E of 119.4 times earnings. That means I'm paying over a hundred rupees for every rupee of profit. For that price, I expect a wonderful business growing steadily. What do I get? Sales actually fell 0.46% and profits dropped 10.85%. This is not growth; it's shrinkage. The Piotroski F-Score of 3/9 confirms the financial health is deteriorating. As Graham said, price is what you pay, value is what you get. Here, I struggle to see value. The one bright spot is ROCE of 16.70%, which suggests the company earns a reasonable return on capital employed. The latest quarter shows ₹15 Cr sales and ₹3 Cr net profit, a healthy margin. But a single quarter does not make a trend, especially when annual profits are only about ₹4 Cr (given the P/E and market cap). This suggests earnings are lumpy, which is typical of cyclical industrial businesses, not a stable compounder. There is no dividend to compensate me while I wait. Book value and debt-to-equity are unavailable, so I cannot fully assess the balance-sheet risk. With F-Score 3/9, I must assume the worst. The stock has nearly halved from its 52-week high of ₹1123.85, but a falling knife still cuts. At 119 times earnings, with shrinking sales and profits, there is no margin of safety. I would rather miss this opportunity than lose capital. Let the business prove itself with sustained growth and a better price. In the words of Buffett, 'It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price.' This is a fair company at an un-wonderful price.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer